Exchange-Traded Funds, Equity Futures Lower Pre-Bell Friday as Markets Sluggishly Move to Year-End

MT NewswiresDec 27 08:06 ET

BeiGene Gains FDA Nod for TEVIMBRA, Marking Key Progress in Oncology Treatments

BenzingaDec 27 06:01 ET

TEVIMBRA Approved in U.S. for First-line Treatment of Gastric and Gastroesophageal Junction Cancers in Combination With Chemotherapy

BusinesswireDec 27 06:00 ET

BeiGene to Rebrand as BeOne Medicines With Oncology-Focused New Nasdaq Ticker "ONC"

BenzingaDec 23 06:06 ET

BeiGene to Change Nasdaq Ticker Symbol to "ONC" on January 2; Present at 43rd Annual J.P. Morgan Healthcare Conference

BusinesswireDec 23 06:00 ET

Express News | Beigene to Change Nasdaq Ticker Symbol to “Onc” on January 2; Present at 43Rd Annual J.P. Morgan Healthcare Conference

ReutersDec 23 06:00 ET